This Research Topic is the second volume in the series: Cuproptosis and Tumors. The previous volume can be viewed here:
Volume I Cuproptosis, a recently identified form of cell death, represents a burgeoning area of research with significant implications for both tumor and non-tumor diseases. Unlike other forms of programmed cell death, such as apoptosis or necroptosis, cuproptosis is characterized by its unique biochemical pathways and cellular effects. Despite its potential, the precise role and mechanisms of cuproptosis in disease progression remain largely undefined, posing a critical gap in our understanding. Recent studies have begun to elucidate the molecular underpinnings of cuproptosis, highlighting its potential as a therapeutic target. However, the translation of these findings into clinical applications is still in its infancy. The need for comprehensive research into the mechanisms of cuproptosis and its implications for disease treatment is evident, as it could pave the way for novel therapeutic strategies that leverage this form of cell death to inhibit disease progression and improve patient outcomes.
This research topic aims to deepen our understanding of cuproptosis, particularly its mechanisms and potential applications in tumor and non-tumor diseases. By exploring the fundamental aspects of cuproptosis and its clinical translation, we seek to answer pivotal questions about its role in disease progression and its viability as a therapeutic target. The research will test hypotheses related to the biochemical pathways involved in cuproptosis and evaluate new therapeutic strategies that could harness this process for disease treatment and prevention.
To gather further insights in the realm of cuproptosis and its clinical applications, we welcome articles addressing, but not limited to, the following themes:
- Molecular mechanisms underlying cuproptosis in tumor cells.
- Comparative studies of cuproptosis and other forms of cell death.
- Development of therapeutic strategies targeting cuproptosis.
- Clinical trials and case studies involving cuproptosis-based treatments.
- Biomarkers for detecting and monitoring cuproptosis in clinical settings.
- The role of cuproptosis in non-tumor diseases and its therapeutic potential.
This Research Topic is the second volume in the series: Cuproptosis and Tumors. The previous volume can be viewed here:
Volume I Cuproptosis, a recently identified form of cell death, represents a burgeoning area of research with significant implications for both tumor and non-tumor diseases. Unlike other forms of programmed cell death, such as apoptosis or necroptosis, cuproptosis is characterized by its unique biochemical pathways and cellular effects. Despite its potential, the precise role and mechanisms of cuproptosis in disease progression remain largely undefined, posing a critical gap in our understanding. Recent studies have begun to elucidate the molecular underpinnings of cuproptosis, highlighting its potential as a therapeutic target. However, the translation of these findings into clinical applications is still in its infancy. The need for comprehensive research into the mechanisms of cuproptosis and its implications for disease treatment is evident, as it could pave the way for novel therapeutic strategies that leverage this form of cell death to inhibit disease progression and improve patient outcomes.
This research topic aims to deepen our understanding of cuproptosis, particularly its mechanisms and potential applications in tumor and non-tumor diseases. By exploring the fundamental aspects of cuproptosis and its clinical translation, we seek to answer pivotal questions about its role in disease progression and its viability as a therapeutic target. The research will test hypotheses related to the biochemical pathways involved in cuproptosis and evaluate new therapeutic strategies that could harness this process for disease treatment and prevention.
To gather further insights in the realm of cuproptosis and its clinical applications, we welcome articles addressing, but not limited to, the following themes:
- Molecular mechanisms underlying cuproptosis in tumor cells.
- Comparative studies of cuproptosis and other forms of cell death.
- Development of therapeutic strategies targeting cuproptosis.
- Clinical trials and case studies involving cuproptosis-based treatments.
- Biomarkers for detecting and monitoring cuproptosis in clinical settings.
- The role of cuproptosis in non-tumor diseases and its therapeutic potential.